Premium
Bicycle Therapeutics PLC (BCYC)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Baker Brothers Life Sciences, L.P. | Institution | 30 356 101 | 43,48% | US$ 127,80M | 2026-01-02 |
| Baker Bros. Advisors LP | Institution | 30 323 301 | 43,44% | US$ 127,66M | 2026-03-31 |
| Forbion Capital Partners B.V. | Institution | 3 468 430 | 4,97% | US$ 14,60M | 2026-03-31 |
| Armistice Capital LLC | Institution | 3 398 000 | 4,87% | US$ 14,31M | 2026-03-31 |
| Long Focus Capital Management LLC | Institution | 3 310 687 | 4,74% | US$ 13,94M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 2 821 171 | 4,04% | US$ 11,88M | 2025-03-31 |
| Acadian Asset Management LLC | Institution | 1 968 025 | 2,82% | US$ 8,29M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 560 882 | 2,24% | US$ 6,57M | 2026-03-31 |
| GSK Equity Investments, Limited | Institution | 1 529 561 | 2,19% | US$ 6,44M | 2026-03-31 |
| Invus Public Equities, L.P. | Institution | 1 368 586 | 1,96% | US$ 5,76M | 2026-03-31 |
| Principal Global Investors, LLC | Institution | 1 174 625 | 1,68% | US$ 4,95M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 028 243 | 1,47% | US$ 4,33M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 979 300 | 1,40% | US$ 4,12M | 2026-03-31 |
| Morgan Stanley | Institution | 618 327 | 0,89% | US$ 2,60M | 2026-03-31 |
| Schroder Investment Management Limited | Institution | 615 833 | 0,88% | US$ 2,59M | 2026-03-31 |
| Dr. Kevin Lee | Initiés | 598 811 | 0,86% | US$ 2,52M | 2026-04-06 |
| Diadema Partners LP | Institution | 476 424 | 0,68% | US$ 2,01M | 2026-03-31 |
| Birchview Capital, LP | Institution | 463 599 | 0,66% | US$ 1,95M | 2026-03-31 |
| Silvercrest Asset Management Group LLC | Institution | 428 684 | 0,61% | US$ 1,80M | 2026-03-31 |
| Marshall Wace LLP | Institution | 377 335 | 0,54% | US$ 1,59M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 377 085 | 0,54% | US$ 1,59M | 2026-03-31 |
| Medical Strategy GmbH | Institution | 343 416 | 0,49% | US$ 1,45M | 2025-06-30 |
| Qube Research & Technologies Ltd | Institution | 308 617 | 0,44% | US$ 1,30M | 2026-03-31 |
| Millennium Management LLC | Institution | 283 986 | 0,41% | US$ 1,20M | 2026-03-31 |
| BlackRock, Inc. | Institution | 278 992 | 0,40% | US$ 1,17M | 2026-03-31 |
| Moore Capital Management, LP | Institution | 275 000 | 0,39% | US$ 1,16M | 2026-03-31 |
| Bessemer Investment Management LLC | Institution | 265 973 | 0,38% | US$ 1,12M | 2026-01-30 |
| Rangeley Capital, LLC | Institution | 232 260 | 0,33% | US$ 977,81k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 218 115 | 0,31% | US$ 918,26k | 2026-03-31 |
| Palo Alto Investors LP | Institution | 201 890 | 0,29% | US$ 849,96k | 2026-03-31 |
| Avicenna Life Sci Master Fund Lp | Institution | 192 296 | 0,28% | US$ 809,57k | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 190 715 | 0,27% | US$ 802,91k | 2026-03-31 |
| Pinnacle Associates, Ltd. | Institution | 185 410 | 0,27% | US$ 780,58k | 2026-03-31 |
| L1 Group Limited | Institution | 184 603 | 0,26% | US$ 777,18k | 2026-03-31 |
| Flax Pond Capital, LLC | Institution | 176 136 | 0,25% | US$ 741,53k | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 164 800 | 0,24% | US$ 693,81k | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 130 422 | 0,19% | US$ 549,08k | 2026-03-31 |
| Manulife Asset Management | Institution | 127 863 | 0,18% | US$ 538,30k | 2026-03-31 |
| Peapod Lane Capital LLC | Institution | 121 106 | 0,17% | US$ 509,86k | 2026-03-31 |
| Persistent Asset Partners Limited | Institution | 120 437 | 0,17% | US$ 507,04k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
